A recent study confirms the oncogenic role of TRIM25, though a different mechanism was demonstrated, with TRIM25 = promoting p53 nuclear export through incorporation with SNORD15B in endometrial cancer cells or the G3BP2 complex, and then nuclear p53 SUMOylation in prostate cancer cells [97,98]. Here, TP53 is linked to prostate carcinoma.